Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417040 · ClinicalTrials.gov registry record · NA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
A NA study of Breast Cancer and Prostate Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 20
- Study locations
NCT00417040: Completed NA study of Breast Cancer and Prostate Cancer, sponsored by Alliance for Clinical Trials in Oncology.
NCT00417040 is a NA study of Breast Cancer and Prostate Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 325 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (88% lower). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00417040, a NA study of Breast Cancer and Prostate Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 20
- Study locations
Study Summary
This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report their symptoms and their ability to carry out daily activities may help doctors understand a patient's use of a computer to report symptoms.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER internet-based intervention
- OTHER assessment of therapy complications
Study Locations (20)
California
- East Bay Radiation Oncology Center - Castro Valley
- Valley Medical Oncology Consultants - Castro Valley - Castro Valley
- Valley Medical Oncology - Fremont
- Contra Costa Regional Medical Center - Martinez
- El Camino Hospital Cancer Center - Mountain View
- Highland General Hospital - Oakland
- Alta Bates Summit Medical Center - Summit Campus - Oakland
- Bay Area Breast Surgeons, Incorporated - Oakland
- CCOP - Bay Area Tumor Institute - Oakland
- Larry G Strieff MD Medical Corporation - Oakland
- Tom K Lee, Incorporated - Oakland
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
- Doctors Medical Center - San Pablo Campus - San Pablo
Illinois
- University of Chicago Cancer Research Center - Chicago
- Louis A. Weiss Memorial Hospital - Chicago
- La Grange Memorial Hospital - La Grange
- Center for Cancer Care at OSF Saint Anthony Medical Center - Rockford
Delaware
- Tunnell Cancer Center at Beebe Medical Center - Lewes
- CCOP - Christiana Care Health Services - Newark
Florida
- Florida Hospital Cancer Institute at Florida Hospital Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2006-12 |
| Est. Completion | 2017-06-01 |
| Phase | NA |
What the finished NCT00417040 record still lists
NCT00417040 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (88% lower).
The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT00417040 names 20 study sites across 4 states, led by California, Illinois, Delaware.
Frequently Asked Questions
What is clinical trial NCT00417040 about?
NCT00417040 is a clinical study titled "Collection of Patient-Reported Symptoms and Performance Status Via the Internet". This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report t...
What is the current status of trial NCT00417040?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2006-12. Estimated completion is 2017-06-01.
What conditions does trial NCT00417040 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Multiple Myeloma, Lung Cancer, Colorectal Cancer.
What interventions are being tested in trial NCT00417040?
The interventions under investigation include: Questionnaire Administration (OTHER), internet-based intervention (OTHER), assessment of therapy complications (OTHER).
Who is sponsoring clinical trial NCT00417040?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00417040 being conducted?
This trial has 20 study locations across California, Delaware, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00417040's enrollment target sits among peer trials
325 262nd of 1224 higher than 962 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia